It is more than just size: Obesity and transplantation

Liver Transplantation

Volumn 19, Issue 8, 2013, Pages 790-795

  Orloff, Mark S ^a   Dokus, M Katherine ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR;

BODY MASS; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; END STAGE LIVER DISEASE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OSTEOARTHRITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL INFECTION; TOTAL QUALITY MANAGEMENT;

EID: 84881109830     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23705     Document Type: Review

References (90)

1. Ogden CL, Carroll MD, Kit BK, Flegal KM,. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012: 1-8.
2. Kim WR, Stock PG, Smith JM, Heimbach JK, Skeans MA, Edwards EB, et al. OPTN/SRTR 2011 annual data report: liver. Am J Transplant 2013; 13 (suppl 1): 73-102.
3. Perez-Protto SE, Quintini C, Reynolds LF, You J, Cywinski JB, Sessler DI, Miller C,. Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl 2013; 19: 907-915.
4. Hakeem AR, Cockbain AJ, Raza SS, Pollard SG, Toogood GJ, Attia MA, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl 2013; 19: 551-562.
5. LaMattina JC, Foley DP, Fernandez LA, Pirsch JD, Musat AI, D'Alessandro AM, Mezrich JD,. Complications associated with liver transplantation in the obese recipient. Clin Transplant 2012; 26: 910-918.
6. Nair S, Cohen DB, Cohen MP, Tan H, Maley W, Thuluvath PJ,. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol 2001; 96: 842-845.
7. Nair S, Verma S, Thuluvath PJ,. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002; 35: 105-109.
8. Pruett T,. Obesity and the liver transplant recipient. Liver Transpl 2002; 8: 171-173.
9. Dick AA, Spitzer AL, Seifert CF, Deckert A, Carithers RL Jr, Reyes JD, Perkins JD,. Liver transplantation at the extremes of the body mass index. Liver Transpl 2009; 15: 968-977.
10. Pelletier SJ, Schaubel DE, Wei G, Englesbe MJ, Punch JD, Wolfe RA, et al. Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl 2007; 13: 1678-1683.
11. Rustgi VK, Marino G, Rustgi S, Halpern MT, Johnson LB, Tolleris C, Taddei TH,. Impact of body mass index on graft failure and overall survival following liver transplant. Clin Transplant 2004; 18: 634-637.
12. Murray KF, Carithers RL Jr,; for AASLD. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005; 41: 1407-1432.
13. Thuluvath PJ,. Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation. Liver Transpl 2007; 13: 1627-1629.
14. Braunfeld MY, Chan S, Pregler J, Neelakanta G, Sopher MJ, Busuttil RW, Csete M,. Liver transplantation in the morbidly obese. J Clin Anesth 1996; 8: 585-590.
15. Fujikawa T, Fujita S, Mizuno S, Shenkman E, Vogel B, Lipori P, et al. Clinical and financial impact of obesity on the outcome of liver transplantation. Transplant Proc 2006; 38: 3612-3614.
16. Hade AM, Shine AM, Kennedy NP, McCormick PA,. Both under-nutrition and obesity increase morbidity following liver transplantation. Ir Med J 2003; 96: 140-142.
17. Hillingsø JG, Wettergren A, Hyoudo M, Kirkegaard P,. Obesity increases mortality in liver transplantation-the Danish experience. Transpl Int 2005; 18: 1231-1235.
18. Leonard J, Heimbach JK, Malinchoc M, Watt K, Charlton M,. The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant 2008; 8: 667-672.
19. Allison DB, Zhu SK, Plankey M, Faith MS, Heo M,. Differential associations of body mass index and adiposity with all-cause mortality among men in the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II) follow-up studies. Int J Obes Relat Metab Disord 2002; 26: 410-416.
20. Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096.
21. O'Brien JM Jr, Phillips GS, Ali NA, Lucarelli M, Marsh CB, Lemeshow S,. Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury. Crit Care Med 2006; 34: 738-744.
22. Peake SL, Moran JL, Ghelani DR, Lloyd AJ, Walker MJ,. The effect of obesity on 12-month survival following admission to intensive care: a prospective study. Crit Care Med 2006; 34: 2929-2939.
23. Pickkers P, de Keizer N, Dusseljee J, Weerheijm D, van der Hoeven JG, Peek N,. Body mass index is associated with hospital mortality in critically ill patients: an observational cohort study. Crit Care Med; doi: 10.1097/CCM.0b013e31828a2aa1.
24. Tremblay A, Bandi V,. Impact of body mass index on outcomes following critical care. Chest 2003; 123: 1202-1207.
25. Gawande A,. Two hundred years of surgery. N Engl J Med 2012; 366: 1716-1723.
26. Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg 1998; 228: 491-507.
27. Khuri SF, Henderson WG, Daley J, Jonasson O, Jones RS, Campbell DA Jr, et al.; for Principal Site Investigators of the Patient Safety in Surgery Study. The Patient Safety in Surgery Study: background, study design, and patient populations. J Am Coll Surg 2007; 204: 1089-1102.
28. Al-Refaie WB, Parsons HM, Henderson WG, Jensen EH, Tuttle TM, Rothenberger DA, et al. Body mass index and major cancer surgery outcomes: lack of association or need for alternative measurements of obesity? Ann Surg Oncol 2010; 17: 2264-2273.
29. Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED,. The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 2009; 49: 140-147.
30. Mullen JT, Moorman DW, Davenport DL,. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009; 250: 166-172.
31. Benoist S, Panis Y, Alves A, Valleur P,. Impact of obesity on surgical outcomes after colorectal resection. Am J Surg 2000; 179: 275-281.
32. Dindo D, Muller MK, Weber M, Clavien PA,. Obesity in general elective surgery. Lancet 2003; 361: 2032-2035.
33. Lynch RJ, Ranney DN, Shijie C, Lee DS, Samala N, Englesbe MJ,. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009; 250: 1014-1020.
34. Greenblatt DY, Rajamanickam V, Mell MW,. Predictors of surgical site infection after open lower extremity revascularization. J Vasc Surg 2011; 54: 433-439.
35. Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, Moorman DW,. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol 2008; 15: 2164-2172.
36. Mustain WC, Davenport DL, Hourigan JS, Vargas HD,. Obesity and laparoscopic colectomy: outcomes from the ACS-NSQIP database. Dis Colon Rectum 2012; 55: 429-435.
37. Sandy-Hodgetts K, Carville K, Leslie GD,. Determining risk factors for surgical wound dehiscence: a literature review. Int Wound J; doi: 10.1111/iwj.12088.
38. Veljkovic R, Protic M, Gluhovic A, Potic Z, Milosevic Z, Stojadinovic A,. Prospective clinical trial of factors predicting the early development of incisional hernia after midline laparotomy. J Am Coll Surg 2010; 210: 210-219.
39. Mehrabi A, Fonouni H, Wente M, Sadeghi M, Eisenbach C, Encke J, et al. Wound complications following kidney and liver transplantation. Clin Transplant 2006; 20 (suppl 17): 97-110.
40. Schaeffer DF, Yoshida EM, Buczkowski AK, Chung SW, Steinbrecher UP, Erb SE, Scudamore CH,. Surgical morbidity in severely obese liver transplant recipients-a single Canadian centre experience. Ann Hepatol 2009; 8: 38-40.
41. Cornier MA, Després JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, et al.; for American Heart Association Obesity Committee of the Council on Nutrition; Physical Activity and Metabolism; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council on the Kidney in Cardiovascular Disease, and Stroke Counci. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011; 124: 1996-2019.
42. Kurth T, Gaziano JM, Rexrode KM, Kase CS, Cook NR, Manson JE, Buring JE,. Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005; 111: 1992-1998.
43. Strazzullo P, D'Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L,. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 2010; 41: e418-e426.
44. Gruson E, Montaye M, Kee F, Wagner A, Bingham A, Ruidavets JB, et al. Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study. Heart 2010; 96: 136-140.
45. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882-889.
46. Wilsgaard T, Arnesen E,. Body mass index and coronary heart disease risk score: the Tromsø study, 1979 to 2001. Ann Epidemiol 2007; 17: 100-105.
47. Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S, et al.; for JACC Study Group. Body mass index and mortality from cardiovascular disease among Japanese men and women: the JACC study. Stroke 2005; 36: 1377-1382.
48. Jonsson S, Hedblad B, Engström G, Nilsson P, Berglund G, Janzon L,. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord 2002; 26: 1046-1053.
49. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
50. Alam M, Siddiqui S, Lee VV, Elayda MA, Nambi V, Yang EY, et al. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J 2011; 75: 1378-1385.
51. Bhamidipati CM, LaPar DJ, Mehta GS, Kern JA, Upchurch GR Jr, Kron IL, Ailawadi G,. Albumin is a better predictor of outcomes than body mass index following coronary artery bypass grafting. Surgery 2011; 150: 626-634.
52. Engel AM, McDonough S, Smith JM,. Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery? Ann Thorac Surg 2009; 88: 1793-1800.
53. Sung SH, Wu TC, Huang CH, Lin SJ, Chen JW,. Prognostic impact of body mass index in patients undergoing coronary artery bypass surgery. Heart 2011; 97: 648-654.
54. Chang SH, Coates PT, McDonald SP,. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007; 84: 981-987.
55. Johansen KL, Young B, Kaysen GA, Chertow GM,. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 2004; 80: 324-332.
56. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981.
57. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, Blair SN,. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34: 389-397.
58. Kragelund C, Omland T,. A farewell to body-mass index? Lancet 2005; 366: 1589-1591.
59. Rothman KJ,. BMI-related errors in the measurement of obesity. Int J Obes (Lond) 2008; 32 (suppl 3): S56-S59.
60. Welborn TA, Dhaliwal SS,. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007; 61: 1373-1379.
61. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al.; for INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
62. Blackett PR, Sanghera DK,. Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction. J Clin Lipidol 2013; 7: 65-81.
63. Herrera BM, Lindgren CM,. The genetics of obesity. Curr Diab Rep 2010; 10: 498-505.
64. Lusis AJ, Attie AD, Reue K,. Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet 2008; 9: 819-830.
65. Cani PD,. Gut microbiota and obesity: lessons from the microbiome. Brief Funct Genomics; doi: 10.1093/bfgp/elt014.
66. Park DY, Ahn YT, Park SH, Huh CS, Yoo SR, Yu R, et al. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 2013; 8: e59470.
67. Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH,. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013; 95: 755-760.
68. Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg 2012; 256: 624-633.
69. Afzali A, Berry K, Ioannou GN,. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl 2012; 18: 29-37.
70. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA,. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249-1253.
71. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J,. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009; 9: 782-793.
72. Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M,. Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl 2008; 14: 1648-1654.
73. Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z,. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011; 17: 15-22.
74. Laryea M, Watt KD, Molinari M, Walsh MJ, McAlister VC, Marotta PJ, et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007; 13: 1109-1114.
75. Ford ES, Giles WH, Dietz WH,. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
76. Kallwitz ER,. Metabolic syndrome after liver transplantation: preventable illness or common consequence? World J Gastroenterol 2012; 18: 3627-3634.
77. Kuo HT, Sampaio MS, Ye X, Reddy P, Martin P, Bunnapradist S,. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation 2010; 89: 1134-1140.
78. Watt KDS,. Obesity and metabolic complications of liver transplantation. Liver Transpl 2010; 16 (suppl 2): S65-S71.
79. Richards J, Gunson B, Johnson J, Neuberger J,. Weight gain and obesity after liver transplantation. Transpl Int 2005; 18: 461-466.
80. Wawrzynowicz-Syczewska M, Karpińska E, Jurczyk K, Laurans L, Boroń-Kaczmarska A,. Risk factors and dynamics of weight gain in patients after liver transplantation. Ann Transplant 2009; 14: 45-50.
81. Anastácio LR, Ferreira LG, de Sena Ribeiro H, Lima AS, Vilela EG, Toulson Davisson Correia MI,. Body composition and overweight of liver transplant recipients. Transplantation 2011; 92: 947-951.
82. Elster EA, Leeser DB, Morrissette C, Pepek JM, Quiko A, Hale DA, et al. Obesity following kidney transplantation and steroid avoidance immunosuppression. Clin Transplant 2008; 22: 354-359.
83. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR,. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420-1427.
84. Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J,. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis. Liver Transpl 2009; 15: 1843-1851.
85. El Atrache MM, Abouljoud MS, Divine G, Yoshida A, Kim DY, Kazimi MM, et al. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transplant 2012; 26: E505-E512.
86. Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A,. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease. Liver Transpl 2009; 15: 1814-1820.
87. O'Riordan A, Dutt N, Cairns H, Rela M, O'Grady JG, Heaton N, Hendry BM,. Renal biopsy in liver transplant recipients. Nephrol Dial Transplant 2009; 24: 2276-2282.
88. Glanton CW, Kao TC, Cruess D, Agodoa LY, Abbott KC,. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index. Kidney Int 2003; 63: 647-653.
89. Pelletier SJ, Maraschio MA, Schaubel DE, Dykstra DM, Punch JD, Wolfe RA, et al. Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl 2003: 77-88.
90. Segev DL, Simpkins CE, Thompson RE, Locke JE, Warren DS, Montgomery RA,. Obesity impacts access to kidney transplantation. J Am Soc Nephrol 2008; 19: 349-355.